MedTrace Logo

Human Epidemiology of Newly Identified Arboviruses

NCT04954352 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 400

Last updated 2021-07-08

No results posted yet for this study

Summary

A local network is being set up to study the impact of arboviruses in our region. It is committed to a one-health approach, in particular with research without a priori for new viruses hosted among vectors and wildlife. The candidates identified by high throughput sequencing approaches will serve as a basis for the development of serological and molecular tools for their detections. These tools will be used to assess the possible circulation of these new viruses in humans in biological collections created within the framework of this project Arbodocc

.

Conditions

  • Arbovirus Infections
  • SARS-CoV Infection

Sponsors & Collaborators

  • UMR ASTRE (CIRAD)

    collaborator UNKNOWN

  • Institut Pasteur

    collaborator INDUSTRY

  • UMR PCCEI

    collaborator UNKNOWN

  • University Hospital, Montpellier

    lead OTHER

Principal Investigators

  • Vincent Foulongne, PhD · UH MONTPELLIER

Eligibility

Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-01-01
Primary Completion
2024-12-20
Completion
2024-12-30

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04954352 on ClinicalTrials.gov